{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:41:59Z","timestamp":1790502119814,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":6580,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1038\/ki.1997.503","type":"journal-article","created":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T09:37:55Z","timestamp":1178530675000},"page":"1685-1692","source":"Crossref","is-referenced-by-count":27,"title":["Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease: Rapid Communication"],"prefix":"10.1016","volume":"52","author":[{"given":"Evi","family":"Trenkwalder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Dieplinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1997.503_bb0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0015","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1172\/JCI115248","article-title":"Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis","volume":"87","author":"Lackner","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00220066","article-title":"The apolipoprotein(a) gene: A transcribed hypervariable locus controlling plasma lipoprotein(a) concentration","volume":"90","author":"Kraft","year":"1992","journal-title":"Hum Genet"},{"key":"10.1038\/ki.1997.503_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10408369609080056","article-title":"Lipoprotein(a) in health and disease","volume":"33","author":"Kronenberg","year":"1996","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1038\/ki.1997.503_bb0035","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.7326\/0003-4819-120-12-199406150-00008","article-title":"Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease","volume":"120","author":"Rader","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.1997.503_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(96)90026-8","article-title":"Lipoprotein(a) in renal disease","volume":"27","author":"Kronenberg","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.1997.503_bb0045","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/ki.1997.233","article-title":"Atherosclerosis and arteriosclerosis in chronic renal failure","volume":"51","author":"London","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.503_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.86.2.475","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients","volume":"86","author":"Cressman","year":"1992","journal-title":"Circulation"},{"key":"10.1038\/ki.1997.503_bb0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/01.ATV.14.9.1405","article-title":"Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease","volume":"14","author":"Kronenberg","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1038\/ki.1997.503_bb0060","first-page":"75","article-title":"Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients","volume":"10","author":"Wanner","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1997.503_bb0065","first-page":"354","article-title":"Lipids and lipoprotein(a) as risk factors for vascular disease in patients on renal replacement therapy","volume":"10","author":"Webb","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1997.503_bb0070","unstructured":"M. Koch, B. Kutkuhn, E. Trenkwalder, D. Bach, B. Grabensee, H. Dieplinger, F. Kronenberg: ApoB, fibrinogen, HDL cholesterol and apo(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol (in press)"},{"key":"10.1038\/ki.1997.503_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/clinchem\/38.3.353","article-title":"Decreases in apolipoprotein(a) after renal transplantation: Implications for lipoprotein(a) metabolism","volume":"38","author":"Black","year":"1992","journal-title":"Clin Chem"},{"key":"10.1038\/ki.1997.503_bb0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.ATV.14.9.1399","article-title":"Apolipoprotein(a) phenotype associated decrease in lipoprotein(a) plasma concentrations after renal transplantation","volume":"14","author":"Kronenberg","year":"1994","journal-title":"Artenoscler Thromb"},{"key":"10.1038\/ki.1997.503_bb0085","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/clinchem\/38.11.2244","article-title":"Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure","volume":"38","author":"Oida","year":"1992","journal-title":"Clin Chem"},{"key":"10.1038\/ki.1997.503_bb0090","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI118487","article-title":"Apolipoprotein(a) kringle 4-containing fragments in urine. Relationship to plasma levels of lipoprotein(a)","volume":"97","author":"Mooser","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.16.8.905","article-title":"Urinary excretion of apo(a) fragments - Role in apo(a) catabolism","volume":"16","author":"Kostner","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.1997.503_bb0100","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0022-2275(20)37150-9","article-title":"Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation","volume":"38","author":"Kronenberg","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1038\/ki.1997.503_bb0105","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1172\/JCI119055","article-title":"Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine","volume":"98","author":"Mooser","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00041433-199504000-00003","article-title":"Biosynthesis and metabolism of lipoprotein(a)","volume":"6","author":"White","year":"1995","journal-title":"Curr Opin Lipidol"},{"key":"10.1038\/ki.1997.503_bb0115","doi-asserted-by":"crossref","first-page":"11643","DOI":"10.1073\/pnas.90.24.11643","article-title":"Cys(4057) of apolipoprotein(a) is essential for lipoprotein(a) assembly","volume":"90","author":"Brunner","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.1997.503_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2362.1996.112255.x","article-title":"The assembly of lipoprotein Lp(a)","volume":"26","author":"Frank","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-2275(20)40065-3","article-title":"Kringle 4 of human apolipoprotein[a] shares a linear antigenic site with human catalase","volume":"36","author":"Dieplinger","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1038\/ki.1997.503_bb0130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0022-2275(20)39975-2","article-title":"Effect of sample storage on the measurement of lipoprotein(a), apolipoproteins B and A-IV, total and high-density lipoprotein cholesterol and triglycerides","volume":"35","author":"Kronenberg","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1038\/ki.1997.503_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116213","article-title":"Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)","volume":"91","author":"Dieplinger","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2362.1992.tb01822.x","article-title":"Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease","volume":"22","author":"Dieplinger","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0145","first-page":"1063","article-title":"Expressed hypervariable polymorphism of apolipoprotein (a)","volume":"49","author":"Kamboh","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1038\/ki.1997.503_bb0150","first-page":"841","article-title":"Fixed-bin analysis for statistical evaluation of continuous distributions of allelic data from VNTR loci, for use in forensic comparisons","volume":"48","author":"Budowle","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1038\/ki.1997.503_bb0155","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.ATV.12.10.1214","article-title":"Apo(a) isoforms predict risk for coronary heart disease: A study in six populations","volume":"12","author":"Sandholzer","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1038\/ki.1997.503_bb0160","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/01.ATV.12.8.895","article-title":"Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication","volume":"12","author":"M\u00f6lgaard","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1038\/ki.1997.503_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.1997.503_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.ATV.17.2.239","article-title":"A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford five-city project participants","volume":"17","author":"Wild","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.1997.503_bb0175","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/bi00455a007","article-title":"Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA","volume":"29","author":"Koschinsky","year":"1990","journal-title":"Biochemistry"},{"key":"10.1038\/ki.1997.503_bb0180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/01.ATV.14.9.1393","volume":"14","author":"Azrolan","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1038\/ki.1997.503_bb0185","first-page":"109","article-title":"Effect of low-dose cyclosporin on plasma lipoproteins and markers of cholestasis in patients with psoriasis","volume":"88","author":"Edwards","year":"1995","journal-title":"Q J Med"},{"key":"10.1038\/ki.1997.503_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(94)90851-6","article-title":"Does cyclosporin affect lipoprotein(a) concentrations","volume":"343","author":"Hunt","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/ki.1997.503_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00004872-199506000-00014","article-title":"Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males","volume":"13","author":"Sturrock","year":"1995","journal-title":"J Hypertens"},{"key":"10.1038\/ki.1997.503_bb0200","doi-asserted-by":"crossref","first-page":"28716","DOI":"10.1016\/S0021-9258(19)61964-2","article-title":"Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes","volume":"269","author":"White","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.1997.503_bb0205","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/bi00234a029","article-title":"Apolipoprotein(a): Expression and characterization of a recombinant form of the protein in mammalian cells","volume":"30","author":"Koschinsky","year":"1991","journal-title":"Biochemistry"},{"key":"10.1038\/ki.1997.503_bb0210","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1021\/bi00206a041","article-title":"High-level expression of various apolipoprotein(a) isoforms by \u201ctransferrinfection\u201d: The role of kringle IV sequences in the extracellular association with low- density lipoprotein","volume":"33","author":"Frank","year":"1994","journal-title":"Biochemistry"},{"key":"10.1038\/ki.1997.503_bb0215","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1172\/JCI117598","article-title":"The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma","volume":"94","author":"Steyrer","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0220","doi-asserted-by":"crossref","first-page":"30320","DOI":"10.1016\/S0021-9258(18)43815-X","article-title":"Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500 \u2192 Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins","volume":"269","author":"Durovic","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.1997.503_bb0225","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0021-9258(19)40146-4","article-title":"Abetalipoproteinemia with an apoB-lOO-lipoprotein(a) glycoprotein complex in plasma: Indication for an assembly defect","volume":"265","author":"Menzel","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.1997.503_bb0230","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI112406","article-title":"Plasma cholesterol metabolism in end-stage renal disease: Difference between treatment by hemodialysis or peritoneal dialysis","volume":"77","author":"Dieplinger","year":"1986","journal-title":"J Clin Invest"},{"issue":"Suppl 31","key":"10.1038\/ki.1997.503_bb0235","first-page":"S16","article-title":"Lipid abnormalities in chronic renal insufficiency","volume":"39","author":"Attman","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.503_bb0240","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ki.1994.115","article-title":"Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis","volume":"45","author":"Maggi","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.503_bb0245","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/ki.1995.239","article-title":"Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment","volume":"47","author":"H\u00f6rkk\u00f6","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.503_bb0250","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1073\/pnas.91.20.9441","article-title":"Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency","volume":"91","author":"Bucala","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.1997.503_bb0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00041433-199206000-00011","article-title":"Investigation of lipoprotein kinetics using endogenous labeling with stable isotopes","volume":"3","author":"Schaefer","year":"1992","journal-title":"Curr Opin Lipidol"},{"key":"10.1038\/ki.1997.503_bb0260","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1172\/JCI118203","article-title":"Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)","volume":"96","author":"Callow","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.503_bb0265","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.ATV.9.5.579","article-title":"Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients","volume":"9","author":"Rath","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1038\/ki.1997.503_bb0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-2275(20)42092-9","article-title":"Quantification of apo[a] and apoB in human atherosclerotic lesions","volume":"32","author":"Pepin","year":"1991","journal-title":"J Lipid Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381560343X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381560343X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:21:01Z","timestamp":1635553261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381560343X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["S008525381560343X"],"URL":"https:\/\/doi.org\/10.1038\/ki.1997.503","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}